ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it will display a number of ground breaking technologies and clinical solutions from the company’s Cardiac Rhythm Management and Atrial Fibrillation Divisions at the 3rd annual Asia-Pacific Heart Rhythm Society Scientific Session (APHRS), which is held in conjunction with the 6th annual Asia-Pacific Atrial Fibrillation Symposium. The new products and virtual reality technology highlight the company’s commitment to providing a comprehensive learning platform alongside the most technologically advanced portfolio of therapies and devices for the treatment of cardiac arrhythmias.
